Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of nivolumab for recurrent/metastatic carcinosarcoma
KCT0004938Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in carcinosarcoma, sponsored by Ono Pharmaceutical. Started Jul 2020; status: completed.
02
Drugs
03
Conditions
carcinosarcoma
Beyond the preview
Go deeper on KCT0004938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004938.